MSS
Clinical trials for MSS explained in plain language.
Never miss a new study
Get alerted when new MSS trials appear
Sign up with your email to follow new studies for MSS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail approach aims to wipe out High-Risk rectal cancer without surgery
Disease control CompletedThis phase 2 trial tests a powerful mix of short-course radiation, chemotherapy (mFOLFOX6), an immunotherapy (PD-1 antibody), and a targeted drug (cetuximab or bevacizumab, depending on genetic markers) in people with high-risk rectal cancer that is mismatch repair proficient (pM…
Matched conditions: MSS
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New combo therapy targets hard-to-treat liver metastases in colorectal cancer
Disease control CompletedThis trial tests a personalized treatment plan for people with advanced colorectal cancer that has spread to the liver and stopped responding to standard treatments. The approach combines a liver-directed chemotherapy (HAIC), a targeted therapy (fruquintinib or cetuximab), and an…
Matched conditions: MSS
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC